DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • France
  • /
  • Capital Goods
Author Program NEWCreate Narrative
EXENS logo

Exosens Stock Price

ENXTPA:EXENS Community·€2.8b Market Cap
  • 3 Narratives written by author
  • 1 Comments on narratives written by author
  • 35 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

EXENS Share Price Performance

€55.95
13.25 (31.03%)
​
€67.13
Fair Value
€55.95
13.25 (31.03%)
16.7% undervalued intrinsic discount
€67.13
Fair Value
Price €55.95
AnalystConsensusTarget €67.13
AnalystHighTarget €75.00
AnalystLowTarget €59.30
Tue, 23 Jun 26
Fair Value€67.13
Share Pricen/a

EXENS Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value €67.13 16.7% undervalued intrinsic discount

EXENS: Defense Sector Demand And Shareholder Shift Will Shape Outlook

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value €75 25.4% undervalued intrinsic discount

Accelerated Digitization And Expanding Defense Spending Will Spur Sensor Demand

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value €59.3 5.6% undervalued intrinsic discount

Geopolitical Instability Will Pressure Global Defense Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
EXENS logo
Exosens
16.7% undervalued intrinsic discount

EXENS: Defense Sector Demand And Shareholder Shift Will Shape Outlook

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 23 Jun
Read Narrative
EXENS logo
Exosens
5.6% undervalued intrinsic discount

Geopolitical Instability Will Pressure Global Defense Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 8 Jul
Read Narrative
EXENS logo
Exosens
25.4% undervalued intrinsic discount

Accelerated Digitization And Expanding Defense Spending Will Spur Sensor Demand

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 7 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
EXENS logo

EXENS: Future Defense Contracts And Funding Will Test Fair Current Pricing

Fair Value: €59.3 5.6% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
EXENS logo

EXENS: Defense Backlog And Higher P E Range Will Support Upside

Fair Value: €67.13 16.7% undervalued intrinsic discount
6 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
EXENS logo

EXENS: Defense Demand And Record Year Will Support Future Earnings Power

Fair Value: €75 25.4% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
1 likeusers have liked this narrative

Snowflake Analysis

High growth potential with adequate balance sheet.

1 Risk
3 Rewards
View Full Analysis

Exosens Key Details

€501.8m

Revenue

€200.1m

Cost of Revenue

€301.7m

Gross Profit

€245.8m

Other Expenses

€55.9m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Oct 27, 2026
1.10
60.13%
11.14%
55.8%
View Full Analysis

About EXENS

Founded
1937
Employees
2000
CEO
Jerome Cerisier
WebsiteView website
www.exosens.com

Exosens, together with its subsidiaries, develops, manufactures, and sells electro-optical technologies in France, Europe, North America, Asia, and internationally. It operates in two segments, Amplification and Detection and Imaging. The company offers image intensifier tubes; cameras, sensors, modules and cores, and imaging systems and solutions, including UV missile warning solution, atmospheric sounder, and spectroradiometer; and detection and imaging products for ions and electrons, photons, and neutrons, as well as micro pore optics and components, such as phosphor screens, resistive glass products, microchannel plates, and electron generator arrays. It also provides bare and energy compensated Geiger- Müller tubes; gamma and neutron detectors; mineral insulated extensions; and silicon photodiodes, as well as methane airborne detection solutions. The company sells its products under the Exosens, Photonis, Xenics, Telops, El-Mul, and Noxant brand names. It serves defense and surveillance, life sciences and environment, industrial control, and nuclear markets. The company was founded in 1937 and is headquartered in Mérignac, France.

Recent EXENS News & Updates

Recent updates

No updates

Exosens Competitors

RXL logo

Rexel

Symbol: ENXTPA:RXL
Market cap: €10.6b
FGR logo

Eiffage

Symbol: ENXTPA:FGR
Market cap: €10.4b
ALO logo

Alstom

Symbol: ENXTPA:ALO
Market cap: €7.2b
NEX logo

Nexans

Symbol: ENXTPA:NEX
Market cap: €6.1b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide